Endocannabinoids serve as retrograde messengers that are released by postsynaptic cells to regulate neurotransmitter release from presynaptic boutons. A new study in this issue of Neuron by Tanimura et al. estab- lishes that most endocannabinoid signaling in the brain is a consequence of the calcium-dependent or receptor-driven generation of the retrograde signal 2-arachidonoylglycerol (2-AG) by diacylglycerol lipase a (DGLa).
For nearly 20 years we have known that depolarizing a postsynaptic cell can elevate calcium, which can in turn trigger the release of a retrograde messenger that acts presynaptically to suppress neurotransmitter release (Llano et al., 1991; Pitler and Alger, 1992) . This form of plasticity came to be known as depolarization-induced suppression of inhibition (DSI), or DSE for excitatory synapses. Following a decade of research, it was discovered that DSI and DSE were mediated by cannabinoid type-1 receptors (CB 1 receptors). The cannabinoid signaling system, so named for its role in the psychotropic effects of marijuana (Cannabis sativa), had long been of interest because of its involvement in perception, motor function, memory, mood, appetite control, and pain. The realization that endogenously produced cannabinoids (endocannabinoids) can act as retrograde messengers sparked a flurry of studies that established the importance of retrograde endocannabinoid signaling in the short-term and long-term regulation of synapses throughout the brain (Heifets and Castillo, 2009; Kano et al., 2009) . It became clear that there are two major ways of evoking endocannabinoid release. For DSI/DSE, endocannabinoid release is driven by a large increase in postsynaptic calcium ( Figure 1A ), whereas for receptor-driven endocannabinoid release (RER), the activation of G q/11 -coupled receptors stimulates endocannabinoid release ( Figure 1B ). Pharmacological and genetic experiments established that for RER, G q/11 -coupled receptor activation causes phospholipase Cb (PLCb) to cleave phosphotidylinositol bisphosphate (PIP 2 ), yielding diacylglycerol (DAG). DAG is then cleaved by DAG lipase (DGL) to generate 2-AG. Importantly, the magnitude of RER can be augmented by elevations of postsynaptic calcium, consistent with the dependence of PLCb on both G q/11 -coupled receptors and calcium.
Even as our understanding of RER advanced considerably, the identity of the endocannabinoid mediating DSI/ DSE, and how this endocannabinoid is synthesized, remained controversial (Figure 1A, top) . Evidence suggested that G q/11 -coupled receptors were not required for DSI/DSE, but the role of DGL and the involvement of 2-AG were less clear. Sometimes, inhibiting DGL prevented RER without affecting DSI/DSE, whereas in other cases inhibiting DGL suppressed DSI/DSE (Kano et al., 2009) . The variability in the results could have reflected either the differential ability of the mechanisms underlying DSI/DSE and RER to evoke endocannabinoid release when some DGL activity remained, or complications associated with the pharmacology. Thus, it was possible that endocannabinoids other than 2-AG, such as anandamide, might contribute to DSI/ DSE. Alternatively, 2-AG could have been involved, but via a pathway involving phospholipase A 1 (PLA 1 ) rather than DGL. Moreover, a molecular approach was needed to determine the roles of DGL isoforms in DSI/DSE and RER.
As detailed in this issue of Neuron, Tanimura et al. (2010) therefore generated two strains of mice deficient in the a and b isoforms of DGL. They found that all aspects of 2-AG signaling and retrograde suppression of synapses were normal in DGLb knockout animals (b-KO). In contrast, in DGLa knockout animals (a-KO), 2-AG content was drastically reduced, and both RER and DSI/DSE were eliminated at inhibitory and excitatory synapses in the cerebellum, the hippocampus, and the striatum. Although the emphasis was on short-term suppression of synaptic strength, they also showed that endocannabinoid-dependent chemical long-term depression at hippocampal inhibitory synapses (iLTD) was greatly diminished within the a-KO. The investigators also included a number of important control experiments showing that in a-KO animals, the distributions of CB 1 receptors, PLCb, and metabotropic glutamate receptors (mGluRs) were normal; mGluRs functioned normally; and dendritic calcium signaling was similar to that of wild-type animals. Oddly, they found that the basal levels of anandamide, an endocannabinoid not synthesized by DGL, were also somewhat reduced in a-KO animals. However, this reduction in anandamide levels (30%-50%) was much less than the reduction in 2-AG levels, and did not seem to be sufficient to account for the elimination of RER and DSI/DSE seen in a-KO animals. Thus, the authors establish that DGLa is the primary enzyme utilized to synthesize the endocannabinoid responsible for all forms of retrograde signaling examined in this study, indicating that 2-AG is the principal molecule involved in this signaling ( Figure 1A , bottom, and Figure 1B ).
This study also raises questions regarding how a calcium increase triggers the synthesis of 2-AG during DSI/DSE. Genetic deletion of PLCb isoforms prevents RER but leaves DSI/DSE unaltered at hippocampal and cerebellar synapses, indicating that PLCb produces DAG in RER Maejima et al., 2005) . The identity of the molecule that drives DAG production during DSI/DSE is still unknown. Other isoforms of PLC that are calcium-dependent but G q/11 -independent are potential candidates, although a number of studies have found a lack of effect of non-isoform-specific PLC inhibitors on DSI (Chevaleyre and Castillo, 2003; Edwards et al., 2006; Szabo et al., 2006) . Alternatively, a second pathway may exist for production of DAG involving the enzyme phosphatidic acid phosphohydralase (PAP) acting on phosphatidic acid (PA) ( Figure 1A, bottom) . The development of more selective pharmacological tools, as well as the use of new genetic manipulations, will be required to fully elucidate the pathway for production of 2-AG during DSI/DSE.
While it seems reasonable to conclude that the bulk of retrograde endocannabinoid signaling throughout the brain, whether driven by calcium alone or by calcium and G q/11 -coupled receptors, is a consequence of 2-AG produced by DGLa, future studies will establish if there are alternative pathways that can lead to the synthesis of 2-AG or other endocannabinoids. It will be of particular interest to examine some forms of endocannabinoid-dependent LTD involving conditioning paradigms that are different from those used to induce RER or DSI/DSE (Heifets and Castillo, 2009 ). For instance, prolonged low-frequency stimulation of afferents in the lateral amygdala results in LTD at inhibitory synapses. This LTD is thought to be dependent on release of anandamide following activation of protein kinase A (Azad et al., 2004) . Examining this form of plasticity in a-KO animals would be highly informative.
The a-KO animals developed by Tanimura et al. (2010) promise to be useful tools in the study of the endocannabinoidsignaling system and behavior. Thus far, most insights into the endocannabinoid signaling system have been provided by global and selective knockouts of CB 1 receptors (CB 1 R-KO animals). It is predicted that behavioral deficits in CB 1 R-KO animals and a-KO animals should be identical for behaviors that are mediated by 2-AG that is synthesized by DGLa. In contrast, behavioral deficits will be different for CB 1 R-KO animals and a-KO animals for behaviors that are mediated by endocannabinoids synthesized by a pathway that does not involve DGLa, and for behaviors relying on 2-AG synthesized by DGLa that act on targets other than CB 1 receptors.
Thus, by creating DGLa and DGLb knockout animals, and establishing the central role of DGLa in the synthesis of 2-AG in retrograde signaling, Tanimura et al. have made a major step forward in our understanding of endocannabinoid signaling, and have opened up promising new areas of research. Schematics are shown for two types of retrograde signaling: depolarization-induced suppression of inhibition and excitation (DSI/DSE; A) and receptordriven endocannabinoid release (RER; B). Advances made in our understanding of retrograde signaling by Tanimura et al. are indicated in red. (A) (Top) For DSI/ DSE, calcium influx resulting from postsynaptic depolarization stimulates the release of a retrograde messenger that acts at presynaptic cannabinoid type-1 receptors (CB 1 Rs) to suppress transmitter release. There had been controversy over the identity of the retrograde messenger for DSI/DSE and the synthetic pathway involved in the synthesis of this messenger. (A) (Bottom) It is now known that DGLa is necessary for DSI/DSE. This indicates that 2-AG is the endocannabinoid mediator of this signaling. It is unknown how postsynaptic calcium accumulation results in the necessary diacylglycerol (DAG) production required for DGLa-dependent formation of 2-AG. Two possibilities include phospholipase C (PLC) activation without G q/11 -coupled receptor activity or conversion of phosphatidic acid (PA) to DAG by PA phosphohydralase (PAP). (B) Activation of G q/11 -coupled receptors stimulates the release of 2-AG, which acts at presynaptic CB 1 Rs to suppress transmitter release. This process is enhanced by increases in postsynaptic calcium levels. Activation of G q/11 -coupled receptors stimulates PLCb, leading to formation of DAG. DAG is then converted to the endocannabinoid 2-AG by DGL. It was not previously known which isoform of DGL (a or b) was involved in RER. It is now known that RER is mediated by 2-AG that is synthesized by DGLa.
